bioRxivCell BiologyPreprint
Mutations in GPNMB associated with Amyloid cutis dyschromica alter intracellular trafficking and processing of GPNMB
Abstract
Amyloid cutis dyschromica (ACD) is a rare skin condition characterized by focal areas of hyperpigmentation with hypopigmented macules and distinct regions of amyloid deposition. Until recently, the genetic cause of ACD remained unknown. Several studies have since named GPNMB truncation mutations as causal, with protein loss-of-function underlying ACD pathogenesis. GPNMB missense mutations have also been observed in patients, but these are less well characterized; especially on a cellular level. Here, we observed that GPNMB missense mutations implicated in familial ACD show distinct cellular phenotypes that result in impaired protein maturation and processing from the endoplasmic reticulum (ER) to the trans-Golgi network (TGN), prompting failed trafficking to lysosomes. These missense mutations also show failed secretion of the extracellular fragment of GPNMB, a well-characterized property of the protein. Overall, this work highlights previously undescribed cellular characteristics of GPNMB missense mutations implicated in ACD and helps to better inform the clinically observed phenotypes, as well as underscore GPNMBs role at melanosomes.
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Glial contribution to cyclodextrin-mediated reversal of cholesterol accumulation in murine NPC1-deficient neurons in vivo
Amélie Barthelemy, Valérie Demais, … Frank W. Pfrieger·Neurobiology of DiseasePeer-reviewed·Aug 5, 2021
- Bidirectional regulation of glycoprotein nonmetastatic melanoma protein B by β-glucocerebrosidase deficiency in GBA1 isogenic dopaminergic neurons from a patient with Gaucher disease and parkinsonism
Chase Chen, Charis Ma, … Yu Chen·bioRxiv·Jun 23, 2025
- Glycosyltransferase POMGNT1 deficiency affects N-cadherin-mediated cell-cell adhesion
S. I. Noor, M. Hoffmann, … S. Strahl·bioRxiv·Sep 9, 2020
- Histone deacetylase inhibitors correct the cholesterol storage defect in most NPC1 mutant cells
Nina H Pipalia, Kanagaraj Subramanian, … Frederick R Maxfield·bioRxiv·Sep 23, 2016
- GPNMB is a biomarker for lysosomal dysfunction and is secreted via LRRK2-modulated lysosomal exocytosis
Erin C. Bogacki, Gustavo Morrone Parfitt, … Susanne Herbst·Science AdvancesPeer-reviewed·Dec 17, 2025
- Correction of Niemann-Pick type C1 disease with the histone deacetylase inhibitor valproic acid
K. Subramanian, D. M. Hutt, … W. E. Balch·bioRxiv·Aug 4, 2019